No items found.
Hers stands out in the crowded GLP-1 telehealth space by offering a women-focused approach with both injectable and oral weight loss options. As part of the publicly-traded Hims & Hers Health platform, they bring significant resources and brand recognition to the weight loss category, though their compounded medications have drawn FDA scrutiny.
The dual-track approach — offering both GLP-1 injectables and oral medication kits — gives patients more options than most competitors. Oral kits starting at $69/month provide an affordable entry point for those who prefer pills over injections. The app-based experience is polished, with 24/7 provider messaging, habit trackers, and behavioral change tools included at no extra cost. Anti-nausea medication is bundled in, which is a thoughtful touch.
The advertised "starting at" prices require significant upfront commitments — the $199/month injectable price requires a 6-12 month prepaid plan, while monthly billing jumps to $299-$399. The FDA issued a warning letter in September 2025 regarding marketing claims on compounded semaglutide products. GLP-1 injectables are not available in all states, including some major markets. Customer service responsiveness has been a common complaint.
Hers is a solid option for women seeking an accessible, app-driven weight loss program with flexible medication options. The oral medication kits are a genuine differentiator for needle-averse patients. However, be prepared for upfront payment commitments to get the best pricing, and understand that compounded medications are not FDA-approved.
Oral medication kits start at $69/month with a 10-month plan paid in full upfront ($690 total). Compounded GLP-1 injectables start at $199/month with a 6-month plan paid in full upfront ($1,194 total). Shorter terms cost more. No insurance required. FSA/HSA eligible. Anti-nausea medication included at no extra cost if eligible.
Two tracks: compounded semaglutide injections (GLP-1), and oral medication kits that may include combinations of metformin, bupropion, topiramate, vitamin B12, and naltrexone. Hers also lists access to branded GLP-1s (Ozempic, Wegovy, Mounjaro, Zepbound) at higher prices. Compounded medications are not FDA-approved.
Yes, Hers is part of publicly-traded Hims & Hers Health (NYSE: HIMS), founded in 2018 and headquartered in San Francisco. The company is LegitScript certified, uses licensed healthcare providers, and partners with FDA-registered compounding pharmacies. They have served millions of patients across multiple health categories.
No, Hers does not accept insurance. All plans are cash-pay only with straightforward pricing. However, Hers treatments are eligible for HSA and FSA reimbursement, which can save users approximately 30% on average. Multi-month prepaid plans offer the best per-month pricing.
24/7 provider messaging, app-based habit trackers, behavioral change programs, sleep and mindset tools, daily protein recommendations, guided start videos, personalized dosage adjustments, and anti-nausea medication at no extra cost. No separate membership fee — everything is included in the medication plan price.
